- Home
- GERN vs CIFR Comparison
GERN vs CIFR Comparison
Compare GERN & CIFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GERN
- CIFR
- Stock Information
- Founded
- GERN 1990
- CIFR 2021
- Country
- GERN United States
- CIFR United States
- Employees
- GERN N/A
- CIFR N/A
- Industry
- GERN Biotechnology: Pharmaceutical Preparations
- CIFR Investment Bankers/Brokers/Service
- Sector
- GERN Health Care
- CIFR Finance
- Exchange
- GERN Nasdaq
- CIFR Nasdaq
- Market Cap
- GERN 2.5B
- CIFR 1.9B
- IPO Year
- GERN 1996
- CIFR N/A
- Fundamental
- Price
- GERN $3.34
- CIFR $5.50
- Analyst Decision
- GERN Strong Buy
- CIFR Strong Buy
- Analyst Count
- GERN 10
- CIFR 10
- Target Price
- GERN $7.05
- CIFR $7.73
- AVG Volume (30 Days)
- GERN 8.0M
- CIFR 10.9M
- Earning Date
- GERN 11-07-2024
- CIFR 10-31-2024
- Dividend Yield
- GERN N/A
- CIFR N/A
- EPS Growth
- GERN N/A
- CIFR N/A
- EPS
- GERN N/A
- CIFR N/A
- Revenue
- GERN $29,480,000.00
- CIFR $152,466,000.00
- Revenue This Year
- GERN $32,021.10
- CIFR $20.11
- Revenue Next Year
- GERN $298.14
- CIFR $124.53
- P/E Ratio
- GERN N/A
- CIFR N/A
- Revenue Growth
- GERN 9199.68
- CIFR 76.34
- 52 Week Low
- GERN $1.64
- CIFR $2.16
- 52 Week High
- GERN $5.34
- CIFR $7.99
- Technical
- Relative Strength Index (RSI)
- GERN 25.88
- CIFR 43.42
- Support Level
- GERN $3.75
- CIFR $5.19
- Resistance Level
- GERN $4.00
- CIFR $7.67
- Average True Range (ATR)
- GERN 0.17
- CIFR 0.66
- MACD
- GERN -0.06
- CIFR -0.18
- Stochastic Oscillator
- GERN 7.41
- CIFR 12.50
About GERN Geron Corporation
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
About CIFR Cipher Mining Inc.
Cipher Mining Inc ia an emerging technology company that operates in the Bitcoin mining ecosystem in the United States. The company is developing a cryptocurrency mining business, specializing in Bitcoin. The company is expanding and strengthening the Bitcoin network's critical infrastructure in the United States.